BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8603923)

  • 1. Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.
    Porter RM; Leitgeb S; Melton DW; Swensson O; Eady RA; Magin TM
    J Cell Biol; 1996 Mar; 132(5):925-36. PubMed ID: 8603923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis.
    Bickenbach JR; Longley MA; Bundman DS; Dominey AM; Bowden PE; Rothnagel JA; Roop DR
    Differentiation; 1996 Dec; 61(2):129-39. PubMed ID: 8983179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out of balance: consequences of a partial keratin 10 knockout.
    Reichelt J; Bauer C; Porter R; Lane E; Magin V
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2175-86. PubMed ID: 9378767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the suprabasal keratin network by mutation M150T in the helix initiation motif of keratin 10 does not affect cornified cell envelope formation in human epidermis.
    Akiyama M; Takizawa Y; Sawamura D; Matsuo I; Shimizu H
    Exp Dermatol; 2003 Oct; 12(5):638-45. PubMed ID: 14705805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of bullous congenital ichthyosiform erythroderma (BCIE) caused by a mutation in the 1A helix initiation motif of keratin 1.
    Uezato H; Yamamoto Y; Kuwae C; Nonaka K; Oshiro M; Kariya K; Nonaka S
    J Dermatol; 2005 Oct; 32(10):801-8. PubMed ID: 16361731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity in bullous congenital ichthyosiform erythroderma: possible somatic mosaicism for keratin gene mutation in the mildly affected mother of the proband.
    Nomura K; Umeki K; Hatayama I; Kuronuma T
    Arch Dermatol; 2001 Sep; 137(9):1192-5. PubMed ID: 11559215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A keratin 10 gene mutation (Arg156Cys) in a Japanese patient with bullous congenital ichthyosiform erythroderma.
    Saeki H; Hattori N; Mitsui H; Adachi M; Imakado S; Ishibashi Y; Tamaki K
    J Dermatol; 2002 Mar; 29(3):168-71. PubMed ID: 11990254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A keratin K10 gene mutation in a Japanese patient with epidermolytic hyperkeratosis.
    Nomura K; Meng X; Umeki K; Tamai K; Sawamura D; Hashimoto I; Kikuchi T
    Jpn J Hum Genet; 1997 Mar; 42(1):217-23. PubMed ID: 9184002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice.
    Jensen JM; Schütze S; Neumann C; Proksch E
    J Invest Dermatol; 2000 Oct; 115(4):708-13. PubMed ID: 10998148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.
    Porter RM; Reichelt J; Lunny DP; Magin TM; Lane EB
    J Invest Dermatol; 1998 Jun; 110(6):951-7. PubMed ID: 9620304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.
    Müller FB; Huber M; Kinaciyan T; Hausser I; Schaffrath C; Krieg T; Hohl D; Korge BP; Arin MJ
    Hum Mol Genet; 2006 Apr; 15(7):1133-41. PubMed ID: 16505000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE).
    McLean WH; Eady RA; Dopping-Hepenstal PJ; McMillan JR; Leigh IM; Navsaria HA; Higgins C; Harper JI; Paige DG; Morley SM
    J Invest Dermatol; 1994 Jan; 102(1):24-30. PubMed ID: 7507152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ichthyosis bullosa of Siemens--a disease involving keratin 2e.
    McLean WH; Morley SM; Lane EB; Eady RA; Griffiths WA; Paige DG; Harper JI; Higgins C; Leigh IM
    J Invest Dermatol; 1994 Sep; 103(3):277-81. PubMed ID: 7521371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event.
    Lacz NL; Schwartz RA; Kihiczak G
    Int J Dermatol; 2005 Jan; 44(1):1-6. PubMed ID: 15663649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild recessive bullous congenital ichthyosiform erythroderma due to a previously unidentified homozygous keratin 10 nonsense mutation.
    Tsubota A; Akiyama M; Kanitakis J; Sakai K; Nomura T; Claudy A; Shimizu H
    J Invest Dermatol; 2008 Jul; 128(7):1648-52. PubMed ID: 18219278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders.
    Arin MJ; Longley MA; Wang XJ; Roop DR
    J Cell Biol; 2001 Feb; 152(3):645-9. PubMed ID: 11157989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mutations in keratin 1 that cause bullous congenital ichthyosiform erythroderma and keratin 2e that cause ichthyosis bullosa of Siemens.
    Whittock NV; Ashton GH; Griffiths WA; Eady RA; McGrath JA
    Br J Dermatol; 2001 Aug; 145(2):330-5. PubMed ID: 11531804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1.
    Kremer H; Lavrijsen AP; McLean WH; Lane EB; Melchers D; Ruiter DJ; Mariman EC; Steijlen PM
    J Invest Dermatol; 1998 Dec; 111(6):1224-6. PubMed ID: 9856846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous congenital ichthyosiform erythroderma of Brocq.
    Kucharekova M; Mosterd K; Winnepenninckx V; van Geel M; Sommer A; van Steensel MA
    Int J Dermatol; 2007 Nov; 46 Suppl 3():36-8. PubMed ID: 17973888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolytic hyperkeratosis.
    Kwak J; Maverakis E
    Dermatol Online J; 2006 Sep; 12(5):6. PubMed ID: 16962021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.